Home/Filings/4/0000899243-23-009587
4//SEC Filing

Sanford Svai S 4

Accession 0000899243-23-009587

CIK 0001856725other

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 4:05 PM ET

Size

5.0 KB

Accession

0000899243-23-009587

Insider Transaction Report

Form 4
Period: 2023-03-22
Sanford Svai S
Chief Financial Officer
Transactions
  • Tax Payment

    Class A Common Stock

    2023-03-22$5.95/sh3,355$19,962119,597 total
Footnotes (2)
  • [F1]Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Sanford on March 22, 2022.
  • [F2]Includes 2,214 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 1, 2022.

Issuer

Rani Therapeutics Holdings, Inc.

CIK 0001856725

Entity typeother

Related Parties

1
  • filerCIK 0001591411

Filing Metadata

Form type
4
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 4:05 PM ET
Size
5.0 KB